(Q53223639)
Statements
A phase II study of weekly paclitaxel/estramustine/carboplatin in hormone-refractory prostate cancer. (English)
William Berry
David Friedland
John Fleagle
Don Jackson
Des Ilegbodu
Kristi A Boehm
Lina Asmar
1 September 2006
5
2
131-137